Loading...

ENGN ENGENE THERAPEUTICS INC Management Changes 8-K Filing

NGN

NGN

ENGENE THERAPEUTICS INC

(ENGN)

2024 8-K

Management Changes

Name Change Notice

Sales Agreement

Financial Results Announced

Loan Agreement Update

Loan Agreement Update

Financial Results Report

Public Offering Announced

Clinical Trial Update

Board Amendment Approved

Board Appointments

Management Change

Financial Results Report

Enrollment Milestone

Financial Statements

Equity Offerings

Geographic Expansion

Financial Results

Share Sale Agreement

Loan Agreement Update

Private Placement

Leadership Changes

Quarterly Results

Corporate Update

External Links:

enGene Holdings Inc. announced several executive leadership changes, including the appointment of Dr. Anthony Cheung as Chief Scientific Officer and Dr. Alexander Nichols as Chief Strategy and Operations Officer, while Dr. James Sullivan will depart the company with a separation agreement entitling him to $485,000 in salary over 12 months and other benefits.

AI Assistant

ENGENE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.